Mark S. Gelder MD - 02 Aug 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ Mark Guerin, Attorney-in-Fact
Issuer symbol: TRAW
Transactions as of: 02 Aug 2022
Net transactions value: -$1,498
Form type: 4
Filing time: 04 Aug 2022, 16:34:22 UTC
Previous filing: 09 Feb 2022
Next filing: 08 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+4,650	+195%		7,031	02 Aug 2022	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$1,498	-1,135	-16%	$1.32	5,896	03 Aug 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-4,650	-33%	$0.000000	9,300	02 Aug 2022	Common Stock	4,650		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.